MA27037A1 - Amides d'acide anthranilique avec une chaine laterale heteroarylsulfonyle, procede pour leur fabrication, leur utilisation comme medicament et comme agent de diagnostic ainsi que les preparations pharmaceutiques en contenant - Google Patents

Amides d'acide anthranilique avec une chaine laterale heteroarylsulfonyle, procede pour leur fabrication, leur utilisation comme medicament et comme agent de diagnostic ainsi que les preparations pharmaceutiques en contenant

Info

Publication number: MA27037A1
Authority: MA; Morocco
Prior art keywords: drug; manufacture; side chain; acid amides; same
Prior art date: 2001-06-12

Application number

MA27434A

Other languages

English (en)

Inventor

Joachim Brendel

Thomas Bohme

Stefan Peukert

Heinz-Werner Kleemann

Original Assignee

Aventis Pharma Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-06-12

Filing date

2003-12-10

Publication date

2004-12-20

2003-12-10 Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh

2004-12-20 Publication of MA27037A1 publication Critical patent/MA27037A1/fr

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/12—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/34—Sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Cardiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Heart & Thoracic Surgery (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Plural Heterocyclic Compounds (AREA)
Quinoline Compounds (AREA)
Pyridine Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

MA27434A 2001-06-12 2003-12-10 Amides d'acide anthranilique avec une chaine laterale heteroarylsulfonyle, procede pour leur fabrication, leur utilisation comme medicament et comme agent de diagnostic ainsi que les preparations pharmaceutiques en contenant MA27037A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE10128331A DE10128331A1 (de)	2001-06-12	2001-06-12	Anthranilsäureamide mit Heteroarylsulfonyl-Seitenkette, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen

Publications (1)

Publication Number	Publication Date
MA27037A1 true MA27037A1 (fr)	2004-12-20

Family

ID=7687941

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA27434A MA27037A1 (fr)	2001-06-12	2003-12-10	Amides d'acide anthranilique avec une chaine laterale heteroarylsulfonyle, procede pour leur fabrication, leur utilisation comme medicament et comme agent de diagnostic ainsi que les preparations pharmaceutiques en contenant

Country Status (41)

Country	Link
US (2)	US6903216B2 (fr)
EP (1)	EP1399423B9 (fr)
JP (1)	JP4422477B2 (fr)
KR (1)	KR100863924B1 (fr)
CN (1)	CN1247544C (fr)
AR (1)	AR036045A1 (fr)
AT (1)	ATE378318T1 (fr)
AU (1)	AU2002316939B2 (fr)
BG (1)	BG108415A (fr)
BR (1)	BR0210374A (fr)
CA (1)	CA2450076C (fr)
CO (1)	CO5540283A2 (fr)
CR (1)	CR7140A (fr)
CY (1)	CY1107427T1 (fr)
CZ (1)	CZ20033361A3 (fr)
DE (2)	DE10128331A1 (fr)
DK (1)	DK1399423T3 (fr)
EC (1)	ECSP034883A (fr)
EE (1)	EE05196B1 (fr)
ES (1)	ES2295360T3 (fr)
HK (1)	HK1065316A1 (fr)
HR (1)	HRP20031028A2 (fr)
HU (1)	HUP0400159A3 (fr)
IL (2)	IL159247A0 (fr)
MA (1)	MA27037A1 (fr)
MX (1)	MXPA03010875A (fr)
MY (1)	MY138341A (fr)
NO (1)	NO20035450D0 (fr)
NZ (1)	NZ530081A (fr)
OA (1)	OA12631A (fr)
PE (1)	PE20021066A1 (fr)
PL (1)	PL364371A1 (fr)
PT (1)	PT1399423E (fr)
RS (1)	RS97703A (fr)
RU (1)	RU2293727C2 (fr)
SK (1)	SK15222003A3 (fr)
TN (1)	TNSN03134A1 (fr)
TW (1)	TWI304400B (fr)
UA (1)	UA75412C2 (fr)
WO (1)	WO2002100825A2 (fr)
ZA (1)	ZA200308520B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10128331A1 (de) *	2001-06-12	2002-12-19	Aventis Pharma Gmbh	Anthranilsäureamide mit Heteroarylsulfonyl-Seitenkette, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen
US7119112B2 (en) *	2002-02-28	2006-10-10	Icagen, Inc.	Sulfonamides as potassium channel blockers
CN1659142A (zh) *	2002-04-26	2005-08-24	石原产业株式会社	吡啶化合物或其盐和含有它们的除草剂
EP1388535A1 (fr) *	2002-08-07	2004-02-11	Aventis Pharma Deutschland GmbH	Arylcycloalkylamines acylés et leurs utilisations comme produits pharmaceutiques
DE10312061A1 (de) *	2003-03-18	2004-09-30	Aventis Pharma Deutschland Gmbh	Kombination von Phenylcarbonsäureamiden mit Blockern des IK-Kanals und deren Verwendung zur Behandlung von Vorhofarrhythmien
GB0315950D0 (en)	2003-06-11	2003-08-13	Xention Discovery Ltd	Compounds
EP1489071A1 (fr) *	2003-06-18	2004-12-22	4Sc Ag	Dérivés de 3,4-dihydro-1H-isoquinoline N-substitués utilisés comme modulateurs de canaux de potassium
WO2005016897A1 (fr)	2003-08-08	2005-02-24	Janssen Pharmaceutica, N.V.	Procede pour preparer des composes de 2- (quinoxaline-5-ylsulfonylamino) -benzamide
DE10341233A1 (de) *	2003-09-08	2005-03-24	Aventis Pharma Deutschland Gmbh	Kombination von Phenylcarbonsäureamiden mit beta-Adrenozeptoren-Blockern und deren Verwendung zur Behandlung von Vorhofarrhythmien
DE102004009931A1 (de) *	2004-02-26	2005-09-15	Aventis Pharma Deutschland Gmbh	Kv1.5-Blocker zur selektiven Steigerung der Vorhofkontraktilität und Behandlung der Herzinsuffizienz
GB0412986D0 (en)	2004-06-10	2004-07-14	Xention Discovery Ltd	Compounds
US7569589B2 (en)	2004-07-29	2009-08-04	Merck & Co., Inc.	Potassium channel inhibitors
AU2005289887A1 (en)	2004-09-24	2006-04-06	Janssen Pharmaceutica, N.V.	Sulfonamide compounds
US7576212B2 (en)	2004-12-09	2009-08-18	Xention Limited	Thieno[2,3-B] pyridines as potassium channel inhibitors
GB0525164D0 (en)	2005-12-09	2006-01-18	Xention Discovery Ltd	Compounds
MX2008012920A (es) *	2006-04-27	2008-10-15	Sanofi Aventis Deutschland	Inhibidores de los canales de iones task-1 y task-3.
WO2008124524A2 (fr) *	2007-04-03	2008-10-16	Janssen Pharmaceutica N.V.	Composés de sulfonamide d'aryle comme modulateurs de récepteur cck2
GB0815784D0 (en)	2008-08-29	2008-10-08	Xention Ltd	Novel potassium channel blockers
GB0815781D0 (en)	2008-08-29	2008-10-08	Xention Ltd	Novel potassium channel blockers
GB0815782D0 (en)	2008-08-29	2008-10-08	Xention Ltd	Novel potassium channel blockers
SI2448909T1 (sl) *	2009-06-29	2013-07-31	Merz Pharma Gmbh & Co. Kgaa	Postopek za pripravo 1-amino-1,3,3,5,5-pentametilcikloheksana
PT2448582T (pt)	2009-06-29	2017-07-10	Agios Pharmaceuticals Inc	Compostos e composições terapêuticas
WO2011010132A1 (fr) *	2009-07-21	2011-01-27	Astrazeneca Ab	Composé 600
FR2967674B1 (fr) *	2010-11-23	2012-12-14	Pf Medicament	Derives d'heteroarylsulfonamides, leur preparation et leur application en therapeutique humaine
GB201105659D0 (en)	2011-04-01	2011-05-18	Xention Ltd	Compounds
NO3175985T3 (fr)	2011-07-01	2018-04-28
JP2015504923A (ja)	2012-01-27	2015-02-16	ギリアードサイエンシーズ，インコーポレイテッド	後期ナトリウムイオンチャネル遮断剤およびカリウムイオンチャネル遮断剤を使用する併用療法
US9701627B2 (en) *	2014-06-16	2017-07-11	University Of Maryland, Baltimore	LRRK2 GTP binding inhibitors for treatment of Parkinson's disease and neuroinflammatory disorders
WO2019031472A1 (fr) *	2017-08-07	2019-02-14	国立大学法人広島大学	NOUVEAU COMPOSÉ À BASE D'ACIDE ANTHRANILIQUE, ET INHIBITEUR DE Pin1, AGENT THÉRAPEUTIQUE CONTRE LES MALADIES INFLAMMATOIRES AINSI QU'AGENT THÉRAPEUTIQUE CONTRE LE CANCER METTANT EN ŒUVRE CELUI-CI

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100189863B1 (ko)	1993-12-27	1999-06-01	나이또 하루오	안트라닐산 유도체
US5670504A (en)	1995-02-23	1997-09-23	Merck & Co. Inc.	2,6-diaryl pyridazinones with immunosuppressant activity
US6083986A (en)	1996-07-26	2000-07-04	Icagen, Inc.	Potassium channel inhibitors
DK173062B1 (da)	1996-10-11	1999-12-13	Krueger As I	Fremgangsmåde til fjernelse af opløste metaller og/eller metalloider fra et vandigt medium indeholdende samme og med et sto
US5969017A (en)	1996-10-31	1999-10-19	Merck & Co., Inc.	Methods of treating or preventing cardiac arrhythmia
US5935945A (en)	1996-10-31	1999-08-10	Merck & Co., Inc.	Methods of treating or preventing cardiac arrhythmia
TW523506B (en)	1996-12-18	2003-03-11	Ono Pharmaceutical Co	Sulfonamide or carbamide derivatives and drugs containing the same as active ingredients
ID26773A (id) *	1998-07-08	2001-02-08	Aventis Pharma Gmbh	Sulfur tersubstitusi pada asam sulfonilaminokarboksilat n-arilamida, persiapan, penggunaan dan persiapan pembuatan obat yang menyertainya
AU754204B2 (en)	1998-09-01	2002-11-07	Bristol-Myers Squibb Company	Potassium channel inhibitors and method
US6458845B1 (en) *	1999-06-24	2002-10-01	Smithkline Beecham Corporation	Macrophage scavenger receptor antagonists
DE19947457A1 (de) *	1999-10-02	2001-04-05	Aventis Pharma Gmbh	2'-Substituierte 1,1'-Biphenyl-2-carbonamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie enthaltende pharmazeutische Zubereitungen
US6531495B1 (en) *	1999-10-02	2003-03-11	Aventis Pharma Deutschland Gmbh	2′-Substituted 1,1′-biphenyl-2-carboxamides, processes for their preparation, their use as medicaments, and pharmaceutical preparations comprising them
DE10128331A1 (de) *	2001-06-12	2002-12-19	Aventis Pharma Gmbh	Anthranilsäureamide mit Heteroarylsulfonyl-Seitenkette, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen

2001
- 2001-06-12 DE DE10128331A patent/DE10128331A1/de not_active Withdrawn
2002
- 2002-05-17 PE PE2002000419A patent/PE20021066A1/es not_active Application Discontinuation
- 2002-05-21 OA OA1200300333A patent/OA12631A/fr unknown
- 2002-05-31 HU HU0400159A patent/HUP0400159A3/hu unknown
- 2002-05-31 KR KR1020037016206A patent/KR100863924B1/ko not_active IP Right Cessation
- 2002-05-31 CN CNB028118502A patent/CN1247544C/zh not_active Expired - Fee Related
- 2002-05-31 CA CA2450076A patent/CA2450076C/fr not_active Expired - Fee Related
- 2002-05-31 PL PL02364371A patent/PL364371A1/xx not_active IP Right Cessation
- 2002-05-31 IL IL15924702A patent/IL159247A0/xx unknown
- 2002-05-31 PT PT02745333T patent/PT1399423E/pt unknown
- 2002-05-31 SK SK1522-2003A patent/SK15222003A3/sk unknown
- 2002-05-31 AU AU2002316939A patent/AU2002316939B2/en not_active Ceased
- 2002-05-31 CZ CZ20033361A patent/CZ20033361A3/cs unknown
- 2002-05-31 BR BR0210374-5A patent/BR0210374A/pt not_active Application Discontinuation
- 2002-05-31 ES ES02745333T patent/ES2295360T3/es not_active Expired - Lifetime
- 2002-05-31 EP EP02745333A patent/EP1399423B9/fr not_active Expired - Lifetime
- 2002-05-31 NZ NZ530081A patent/NZ530081A/en unknown
- 2002-05-31 AT AT02745333T patent/ATE378318T1/de active
- 2002-05-31 DK DK02745333T patent/DK1399423T3/da active
- 2002-05-31 WO PCT/EP2002/005956 patent/WO2002100825A2/fr active IP Right Grant
- 2002-05-31 EE EEP200300558A patent/EE05196B1/xx not_active IP Right Cessation
- 2002-05-31 UA UA2004010206A patent/UA75412C2/uk unknown
- 2002-05-31 RS YU97703A patent/RS97703A/sr unknown
- 2002-05-31 JP JP2003503594A patent/JP4422477B2/ja not_active Expired - Fee Related
- 2002-05-31 DE DE50211213T patent/DE50211213D1/de not_active Expired - Lifetime
- 2002-05-31 MX MXPA03010875A patent/MXPA03010875A/es active IP Right Grant
- 2002-05-31 RU RU2004100302/04A patent/RU2293727C2/ru not_active IP Right Cessation
- 2002-06-10 TW TW091112464A patent/TWI304400B/zh not_active IP Right Cessation
- 2002-06-10 AR ARP020102178A patent/AR036045A1/es active IP Right Grant
- 2002-06-11 MY MYPI20022165A patent/MY138341A/en unknown
- 2002-06-12 US US10/166,595 patent/US6903216B2/en not_active Expired - Lifetime
2003
- 2003-07-08 TN TNPCT/EP2002/005956A patent/TNSN03134A1/en unknown
- 2003-10-31 ZA ZA200308520A patent/ZA200308520B/en unknown
- 2003-11-04 CR CR7140A patent/CR7140A/es not_active Application Discontinuation
- 2003-12-03 EC EC2003004883A patent/ECSP034883A/es unknown
- 2003-12-04 BG BG108415A patent/BG108415A/xx unknown
- 2003-12-08 NO NO20035450A patent/NO20035450D0/no not_active Application Discontinuation
- 2003-12-08 IL IL159247A patent/IL159247A/en not_active IP Right Cessation
- 2003-12-10 MA MA27434A patent/MA27037A1/fr unknown
- 2003-12-11 CO CO03108701A patent/CO5540283A2/es not_active Application Discontinuation
- 2003-12-11 HR HR20031028A patent/HRP20031028A2/hr not_active Application Discontinuation
2004
- 2004-10-20 HK HK04108195A patent/HK1065316A1/xx not_active IP Right Cessation
2005
- 2005-02-08 US US11/052,959 patent/US7235664B2/en not_active Expired - Lifetime
2008
- 2008-02-04 CY CY20081100143T patent/CY1107427T1/el unknown

Also Published As

Publication number	Publication date
DK1399423T3 (da)	2008-03-17
US6903216B2 (en)	2005-06-07
US7235664B2 (en)	2007-06-26
CA2450076A1 (fr)	2002-12-19
HRP20031028A2 (en)	2005-10-31
CZ20033361A3 (cs)	2004-05-12
TWI304400B (en)	2008-12-21
ATE378318T1 (de)	2007-11-15
CN1247544C (zh)	2006-03-29
RU2293727C2 (ru)	2007-02-20
ECSP034883A (es)	2004-01-28
ES2295360T3 (es)	2008-04-16
US20030114499A1 (en)	2003-06-19
JP2004533464A (ja)	2004-11-04
KR20040030668A (ko)	2004-04-09
WO2002100825A2 (fr)	2002-12-19
PL364371A1 (en)	2004-12-13
US20050137200A1 (en)	2005-06-23
EE200300558A (et)	2004-02-16
RU2004100302A (ru)	2005-04-10
BG108415A (en)	2004-07-30
HK1065316A1 (en)	2005-02-18
CR7140A (es)	2004-04-15
KR100863924B1 (ko)	2008-10-17
CY1107427T1 (el)	2012-12-19
UA75412C2 (en)	2006-04-17
IL159247A (en)	2010-06-16
ZA200308520B (en)	2004-09-06
AR036045A1 (es)	2004-08-04
CA2450076C (fr)	2010-11-30
BR0210374A (pt)	2004-07-13
CO5540283A2 (es)	2005-07-29
PE20021066A1 (es)	2003-01-21
OA12631A (fr)	2006-06-14
SK15222003A3 (sk)	2004-06-08
NZ530081A (en)	2005-07-29
HUP0400159A2 (hu)	2004-07-28
HUP0400159A3 (en)	2008-10-28
MY138341A (en)	2009-05-29
CN1529695A (zh)	2004-09-15
EE05196B1 (et)	2009-08-17
EP1399423A2 (fr)	2004-03-24
PT1399423E (pt)	2008-02-07
EP1399423B1 (fr)	2007-11-14
WO2002100825A3 (fr)	2003-12-11
JP4422477B2 (ja)	2010-02-24
EP1399423B9 (fr)	2008-02-27
NO20035450D0 (no)	2003-12-08
MXPA03010875A (es)	2004-02-17
AU2002316939B2 (en)	2006-11-23
RS97703A (en)	2006-12-15
DE10128331A1 (de)	2002-12-19
DE50211213D1 (de)	2007-12-27
IL159247A0 (en)	2004-06-01
TNSN03134A1 (en)	2005-12-23

Publication	Publication Date	Title
MA27037A1 (fr)	2004-12-20	Amides d'acide anthranilique avec une chaine laterale heteroarylsulfonyle, procede pour leur fabrication, leur utilisation comme medicament et comme agent de diagnostic ainsi que les preparations pharmaceutiques en contenant
EE200300529A (et)	2004-02-16	Antraniilhappe amiidid, nende kasutamine ja farmatseutiline preparaat
EA200100524A1 (ru)	2002-02-28	Амиды антраниловой кислоты и их применение в качестве лекарственных средств
CA2431565A1 (fr)	2002-06-20	Nouvelles compositions pharmaceutiques a base d'anticholinergiques et de ciclesonide
DK1289517T3 (da)	2006-04-03	Farmaceutiske sammensætninger indeholdende cannabidiolderivater
BR0010498A (pt)	2002-02-26	Composições modernas de medicamentos à base de compostos anticolinergicamente ativos e beta-miméticos
DE60126321D1 (de)	2007-03-15	Gelsystem zur ocularen verabreichung von arzneimitteln
DZ3227A1 (fr)	2001-07-05	Compositions pharmaceutiques fournissant des concentrations de medicaments ameliorees
RO116342B1 (ro)	2001-01-30	Compoziţie farmaceutică lichidă, orală
IL152578A0 (en)	2003-05-29	Ortho-substituted anthranilic acid amides and their use as medicaments
HUP0104709A2 (hu)	2002-04-29	Eritropoietin vagy eritropoietrinszármazékok alkalmazása agyi iszkémiák kezelésére használható gyógyszer előállítására
WO2003008637A3 (fr)	2003-10-16	Utilisation du genotypage dans l'individualisation des therapies
DZ3103A1 (fr)	2004-06-20	Nouvelles pyrazolo Ä4,3-EÜdiazépines substituées, compositions pharmaceutiques les contenant, utili sation à titre de médicament et procédés pour leurs préparation.
MA26232A1 (fr)	2004-07-01	Procede de reaction d'alcaloides et usage des produits de la reaction dans la preparation de medicaments
TR200003451T2 (tr)	2001-04-20	Pirimidin-Aminometil-Piridin Türevleri, Hazırlanmaları ve helikobakter bakterinin kontrolünde kullanımları
FR2847815B1 (fr)	2006-08-04	Utilisation d'au moins un extrait de miellat de coton comme ingredient actif dans ou pour la preparation d'une composition cosmetique et/ou pharmaceutique.
FR2864090B1 (fr)	2006-01-27	Derives carboxy-reduits de l'acide hyaluronique, leur preparation, leur application comme medicament et les compositions pharmaceutiques les renfermant
SI1399423T1 (sl)	2008-04-30	Amidi antranilne kisline s heteroarilsulfonilno stransko verigo in njihova uporaba kot antiaritmicne ucinkovine
AU2003294834A1 (en)	2004-06-30	Anthranilic acid amide derivatives and their pharmaceutical use
RU95101840A (ru)	1996-12-10	Сложные эфиры циклогексанола и содержащий их фармацевтический препарат
MA27149A1 (fr)	2005-01-03	Les imidazolidines substitues,la methode de leur production,leur utilisation comme un medicament ou comme un moyen de diagnostique et le medicament qui contient les imidazolidines substitues
EA199900878A1 (ru)	2001-02-26	Антиишемическое средство
RU99116456A (ru)	2001-06-10	Лекарственное средство для профилактики и лечения вирусных болезней животных
DE60218683D1 (de)	2007-04-19	Pharmazeutische zusammensetzung für die nasale verabreichung von östradiol und norethisteron
IT1295860B1 (it)	1999-05-28	Medicinale per la cura delle patologie che provocano l'ostruzione respiratoria nasale e di altre patologie ad esse correlate, nonche'